Share on LinkedInShare on LinkedIn

ARTICLE · 19 OCTOBER 2023

HHS Makes History: Recommending That Cannabis Be Reclassified

On August 29, 2023, the U.S. Department of Health and Human Services (HHS) issued a letter formally recommending the U.S. Drug Enforcement Administration...

United StatesCannabis & Hemp
Shulman Rogers
Shulman Rogers

On August 29, 2023, the U.S. Department of Health and Human Services (HHS) issued a letter formally recommending the U.S. Drug Enforcement Administration (DEA) re-classify cannabis from a Schedule I Controlled Substance to a Schedule III Controlled Substance under the federal Controlled Substances Act.

Schedules

Since the founding of the DEA in 1970, cannabis has been listed as a Schedule I substance. Under federal law, Schedule I drugs are defined as having “no currently accepted medical use and a high potential for abuse.” Along with cannabis, other Schedule I drugs include heroin and LSD.

Under federal law, Schedule III drugs are defined as having “moderate to low potential for physical and psychological dependence.” Schedule III drugs include ketamine, anabolic steroids, and testosterone.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from